Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found two records

$75,000.00

Jul 20, 2022

For-profit organization

Agreement:

ARP- A sword and shield immune fusokine against solid malignancies and virus infections

Agreement Number:

993313

Duration: from Jul 20, 2022 to May 1, 2023
Description:

Combination therapies have been evaluated in the clinic to achieve multi-functionality. However, some drug combination therapies can have multiple outcomes that may not be synergistic, causing side effects. In this project, the aim is to investigate the immunostimulatory properties of the drug product in cancer patient's immune cells, identify biomarkers in immune cells from cancer patients at different disease stages, and assess the anti-cancer efficacy of the product in a cancer disease model as a standalone treatment and in combination with other known therapy.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Montreal, Quebec, CA H4A 2R2

$49,680.00

Aug 16, 2021

For-profit organization

Agreement:

ARP - Feasibility Study for Production of a Biologic

Agreement Number:

977002

Duration: from Aug 16, 2021 to Jan 31, 2022
Description:

Feasibility study to determine the optimal purification methods to obtain higher yields, purity, and stability of glycosylated proteins.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Montreal, Quebec, CA H4A 2R2